Patents by Inventor Michael J. Dart

Michael J. Dart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040077616
    Abstract: The present invention relates to the use of compounds of formula (I) 1
    Type: Application
    Filed: October 22, 2002
    Publication date: April 22, 2004
    Inventors: Youssef L. Bennani, William H. Bunnelle, Sou-Jen Chang, Sanjay R. Chemburkar, Jinhua Chen, Michael J. Dart, Dilinie P. Fernando, Yi-Yin Ku, Mark Lockwood, Lei Wang
  • Publication number: 20040044029
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: August 14, 2002
    Publication date: March 4, 2004
    Inventors: Michael J. Dart, Xenia B. Searle, Karin Tietje, Richard B. Toupence
  • Publication number: 20030225268
    Abstract: Compounds of formula I: 1
    Type: Application
    Filed: April 11, 2003
    Publication date: December 4, 2003
    Inventors: William H. Bunnelle, Daniela Barlocco Cristina, Jerome F. Daanen, Michael J. Dart, Michael D. Meyer, Keith B. Ryther, Michael R. Schrimpf, Kevin B. Sippy, Richard B. Toupence
  • Patent number: 6403575
    Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula I: or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula I above which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: June 11, 2002
    Assignee: Abbott Laboratories
    Inventors: Mark W. Holladay, Stephen P. Arneric, Hao Bai, Michael J. Dart, Nan-Horng Lin, John K. Lynch, Yat Sun Or, Keith B. Ryther, James P. Sullivan, James T. Wasicak, Paul P. Ehrlich
  • Patent number: 6133253
    Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula I: ##STR1## or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula I above which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
    Type: Grant
    Filed: December 9, 1997
    Date of Patent: October 17, 2000
    Assignee: Abbott Laboratories
    Inventors: Mark W. Holladay, Stephen P. Arneric, Hao Bai, Michael J. Dart, Nan-Horng Lin, John K. Lynch, Yat Sun Or, Keith B. Ryther, James P. Sullivan, James T. Wasicak, Paul P. Ehrlich
  • Patent number: 6001849
    Abstract: Novel heterocyclic ether compounds having the formula: ##STR1## wherein A, m, R, X, Y.sup.1, Y.sup.2 and Y.sup.3 are specifically defined, which are useful in selectively controlling chemical synaptic transmission; therapeutically-effective pharmaceutical compositions thereof; and use of said compositions to selectively control synaptic transmission in mammals.
    Type: Grant
    Filed: April 11, 1997
    Date of Patent: December 14, 1999
    Assignee: Abbott Laboratories
    Inventors: Richard L. Elliott, Keith B. Ryther, Mark W. Holladay, James T. Wasicak, Jerome F. Daanen, Nan-Horng Lin, Michael J. Dart, Yun He, Yihong Li